Pereira Neto Carlos Cunha, Roman Chris, Johnson Mahlon, Jagasia Madan, Martin William H, Delbeke Dominique
Department of Radiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Mol Imaging Biol. 2004 Jan-Feb;6(1):63-7. doi: 10.1016/j.mibio.2004.01.023.
Erdheim-Chester disease (ECD) is a disseminated xanthogranulomatous infiltrative disease of unknown etiology due to infiltration of different organs and bones by foamy histiocytes. A 37-year-old male with cerebral and periorbital lesions was diagnosed with this rare disease and was evaluated with magnetic resonance imaging (MRI) and 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) with positron emission tomography/computed tomography (PET/CT) imaging at baseline and following therapy. FDG-PET imaging allowed accurate evaluation of the extent of the disease at baseline, as well as assessment of response to therapy.
厄尔德海姆-切斯特病(ECD)是一种病因不明的播散性黄瘤性浸润性疾病,由泡沫状组织细胞浸润不同器官和骨骼所致。一名患有脑部和眶周病变的37岁男性被诊断为这种罕见疾病,并在基线期和治疗后接受了磁共振成像(MRI)以及2-脱氧-2-[(18)F]氟代-D-葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)成像评估。FDG-PET成像能够在基线期准确评估疾病范围,并评估治疗反应。